PRISCO, DOMENICO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 24.935
EU - Europa 17.208
AS - Asia 3.233
AF - Africa 120
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 8
Totale 45.522
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 24.857
RU - Federazione Russa 5.555
PL - Polonia 3.982
IE - Irlanda 1.933
IT - Italia 1.653
SE - Svezia 1.586
SG - Singapore 1.018
HK - Hong Kong 829
UA - Ucraina 753
DE - Germania 718
CN - Cina 573
FI - Finlandia 361
IN - India 339
GB - Regno Unito 292
JO - Giordania 183
TR - Turchia 146
CH - Svizzera 98
VN - Vietnam 96
FR - Francia 92
CI - Costa d'Avorio 78
CA - Canada 76
ES - Italia 55
AT - Austria 32
SC - Seychelles 32
BE - Belgio 30
KR - Corea 20
NL - Olanda 20
CZ - Repubblica Ceca 19
DK - Danimarca 7
EU - Europa 7
IR - Iran 7
JP - Giappone 7
SA - Arabia Saudita 7
MU - Mauritius 6
AU - Australia 5
BR - Brasile 5
BG - Bulgaria 4
EG - Egitto 4
PT - Portogallo 4
NZ - Nuova Zelanda 3
RO - Romania 3
EC - Ecuador 2
IL - Israele 2
IQ - Iraq 2
MX - Messico 2
NO - Norvegia 2
UZ - Uzbekistan 2
AP - ???statistics.table.value.countryCode.AP??? 1
AR - Argentina 1
CL - Cile 1
CO - Colombia 1
EE - Estonia 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
LT - Lituania 1
LV - Lettonia 1
MK - Macedonia 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 45.522
Salva come PNG Salva come JPEG
Città #
Santa Clara 4.091
Warsaw 3.980
Fairfield 3.249
Dublin 1.916
Chandler 1.797
Ashburn 1.533
Woodbridge 1.490
Seattle 1.295
Cambridge 1.220
Jacksonville 1.220
Houston 1.168
Wilmington 1.052
Singapore 824
Ann Arbor 520
Lawrence 506
Princeton 501
Altamura 472
Hong Kong 442
Boston 313
Mumbai 302
Florence 296
Boardman 277
Medford 241
Beijing 215
Buffalo 214
Moscow 209
San Diego 190
New York 136
Shanghai 130
Bern 94
Los Angeles 93
Norwalk 86
Abidjan 78
Izmir 77
Dong Ket 76
Falls Church 73
Kent 65
Milan 61
Hillsboro 56
Toronto 52
Andover 43
Auburn Hills 43
Barcelona 41
Yubileyny 39
London 38
Munich 38
Rome 34
Vienna 32
Frankfurt Am Main 31
Brussels 30
Redwood City 28
West Jordan 28
Phoenix 27
Dearborn 26
Latina 26
Verona 26
Helsinki 24
Salerno 22
Guangzhou 20
Brno 17
Washington 17
Seoul 16
Redmond 13
Bologna 12
Prato 12
Arezzo 11
Bari 11
Castelliri 11
Fuzhou 11
Kilburn 11
Pune 11
Laurel 10
Romola 9
Naples 8
Palermo 8
Turin 8
Copenhagen 7
Genoa 7
Old Bridge 7
Wuhan 7
Chicago 6
Hounslow 6
Jinan 6
Nanjing 6
New Bedfont 6
Pamplona 6
Sesto Fiorentino 6
Siena 6
St Petersburg 6
Bremen 5
Campi Bisenzio 5
Chiswick 5
Hanover 5
Lappeenranta 5
Leawood 5
Montréal 5
Paris 5
Pescara 5
Reggio Nell'emilia 5
Riyadh 5
Totale 31.539
Salva come PNG Salva come JPEG
Nome #
Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection 273
Behçet's syndrome patients exhibit specific microbiome signature. 271
Erythrocyte oxidative stress is associated with cell deformability in patients with retinal vein occlusion 270
An approach to differential diagnosis of antiphospholipid antibody syndrome and related conditions. 264
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. 249
A severe case of warfarin-canrenoate interaction: a role for genetic predisposition? 246
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 244
High lipoprotein (a) levels are associated with an increased risk of retinal vein occlusion 243
Effect of low-dose heparin treatment on fibrinolysis in patients with previous myocardial infarction 240
Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis 239
Risk of bleeding in very old atrial fibrillation patients on warfarin: Relationship with ageing and CHADS(2) score 236
Vascular and connective tissue features in 5 italian patients with homocystinuria 232
Central vein sign differentiates MS from CNS inflammatory vasculopathies. 230
Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome. 229
Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events. 226
Repeated low-dose courses of rituximab in SLE-associated antiphospholipid syndrome: Data from a tertiary dedicated centre 226
Gender differences in stroke risk of atrial fibrillation patients on oral anticoagulant treatment 222
Diagnosis and treatment of pulmonary embolism: a multidisciplinary approach. 222
Angiotensi-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinmeia increase first-trimester fetal-loss susceptibility 220
Intra-tumoral IFN-gamma-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer 220
Evaluation of traditional and emerging cardiovascular risk factors in patients with non-arteritic anterior ischemic optic neuroparty: a case-control study 216
Role of glycoprotein Ia gene polymorphisms in determinino platelet function in myocardial infarction patients undergoing percutaneous coronary intervention of dual antiplatelet treatment 210
Sirt1 Protects against Oxidative Stress-Induced Apoptosis in Fibroblasts from Psoriatic Patients: A New Insight into the Pathogenetic Mechanisms of Psoriasis 203
Apolipoprotein(a) kringle-IV type 2 copy number variation is associated with venous thromboembolism 201
Perioperative assessment of platelet function by Thromboelastograph Platelet MappingTM in cardiovascular patients undergoing non-cardiac surgery 197
Point-of-care testing of hemostasis in cardiac surgery 192
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 189
Perioperative myocardial infarction in elderly patients with hip fracture. Is there a role for early coronary angiography? 188
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 187
Aumentata produzione di trombossano A2 e di PGE2 con normale conversione di 1-14 C acido arachidonico da parte delle piastrine nei soggetti diabetici. 173
T cells in gastric cancer: friends or foes. 168
First report of FIP1L1-PDGFR alpha-positive eosinophilic granulomatosis with polyangiitis 164
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 164
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 162
Thrombosis in vasculitis: from pathogenesis to treatment 152
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper. 152
D-dimer concentrations during normal pregnancy, as measured by ELISA 150
D-Dimer in intra-uterine growth retardation and gestational hypertension 150
Gastric cancer and the epoch of immunotherapy approaches 148
Behcet's Syndrome as a Model of Thrombo-Inflammation: The Role of Neutrophils 147
Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients 146
Altered intraplatelet arachidonic acid metabolism during the acute state of unstable angina 144
Belimumab reduces antiphospholipid antibodies in SLE patients independently of hydroxychloroquine treatment 144
Assessment of platelet function on whole blood by multiple electrode aggregometry in high-risk patients with coronary artery disease receiving antiplatelet therapy 141
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 141
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 140
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 136
Hip fracture unit: beyond orthogeriatrics 135
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 135
ACE DD genotype: an independent predisposition factor to venous thromboembolism. 132
Stem-Cell-Derived Circulating Progenitors Dysfunction in Behçet's Syndrome Patients Correlates With Oxidative Stress 132
Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina 131
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies 130
Age related changes in platelet lipid composition 130
Comorbidities, alone and in combination with D-dimer, as risk factors for recurrence after a first episode of unprovoked venous thromboembolism in the extended follow-up of the prolong study 130
Prostaglandins in squamous cell carcinoma of the larynx: tumor and peritumor synthesis 129
The high prevalence of thermolabile 5,10 methylenetetrahydrofolate reductase (MTHFR) in Italians is not associated to an increased risk for coronary artery disease (CAD) 129
Fibrinolytic inhibitors and fibrin characteristics determine a hypofibrinolytic state in patients with pulmonary embolism. 129
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 129
Platelet synthesis of cyclooxygenase and lipoxygenase products in type I and type II diabetes 128
D-dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction? A pilot study 127
Role of haemorheological factors in patients with retinal vein occlusion. 127
D-dimer plasma levels during normal pregnancy measured by specific ELISA 126
Thrombosis in Autoimmune Diseases: A Role for Immunosuppressive Treatments? 125
Altered membrane fatty acid composition and increased thromboxane A2 generation in platelets from patients with diabetes 125
Ability of whole blood aggregometer to detect platelet hyperaggregability 124
Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies. 124
Association between time of increased fibrinopeptide A levels in plasma and episodes of spontaneous angina: a controlled prospective study 123
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 123
Blood clotting activation during normal pregnancy 123
Neutrophil Activation Promotes Fibrinogen Oxidation and Thrombus Formation in Behçet’s Disease 123
Hyperhomocysteinemia in renal transplant patients as independent cause of endothelial damage and cardiovascular disease. 122
Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus 122
Effect of low-dose heparin on fibrinogen levels in patients with chronic ischemic heart disease. 122
Intravenous immunoglobulin for the secondary prevention of stillbirth in obstetric antiphospholipid syndrome: A case series and systematic review of literature 121
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome 120
Acute T-cell activation is detectable in unstable angina 119
Combination of D-dimer, F1+2 and residual vein obstruction as predictors of VTE recurrence in patients with first VTE episode after OAT withdrawal 119
Behçet's syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects 119
Spontaneous and cold pressor test-induced prostaglandin biosynthesis by human heart 119
Fibrin generation and digestion in patients with angina pectoris 119
Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the Prolong II prospective study 119
Erythrocyte membrane fluidity alterations in sudden sensorineural hearing loss patients: The role of oxidative stress 119
RISK FACTORS FOR CARDIOVASCULAR DISEASE IN RENAL TRANSPLANT RECIPIENTS: NEW INSIGHTS 118
Relationship between classical FDP test and D-dimer assayed both by latex agglutination and ELISA 118
Different models for oral anticoagulation management may be applied provided that minimal assistance criteria are fulfilled: An italian experience 118
Interleukin-17/Interleukin-21 and Interferon-g producing T cells specific for β2 Glycoprotein I in atherosclerosis inflammation of systemic lupus erythematosus patients with antiphospholipid syndrome 118
Evaluation of clotting and fibrinolytic activation after protracted physical exercise 117
Age-related changes in red blood cell lipids 117
Electrophysiologic procedures and activation of the hemostatic system 117
Pathogenesis and potential therapeutic targets in systemic lupus erythematosus: from bench to bedside 117
Altered lipid composition and thromboxane A2 formation in platelets from patients affected by IIa hyperlipoproteinemia 117
Age-related changes in the hemostatic system 116
Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer 116
Thrombophilic risk factors for symptomatic peripheral arterial disease 116
Peripheral ENO1-specific T cells mirror the intratumoral immune response and their presence is a potential prognostic factor for pancreatic adenocarcinoma 116
Anticoagulation quality and the risk of recurrence of venous thromboembolism 114
Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies. 114
Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients. 114
Impaired cardiac PGI2 and PGE2 biosynthesis in patients with angina pectoris 114
Totale 15.793
Salva come PNG Salva come JPEG
Categoria #
all - tutte 133.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 133.027
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.621 0 0 0 0 831 974 817 1.000 748 450 594 207
2020/20215.330 424 406 398 788 289 541 228 426 473 663 288 406
2021/20223.303 88 201 321 155 139 177 100 250 191 126 619 936
2022/20237.923 824 1.491 353 488 605 1.456 1.053 412 773 63 234 171
2023/20243.077 115 329 572 175 199 466 103 585 46 163 156 168
2024/202512.278 677 2.166 1.290 3.134 5.011 0 0 0 0 0 0 0
Totale 45.982